The biotech’s approach to fighting cancer is based around “repolarising” tumour-associated macrophages (TAMs) using small molecule drugs so that they no longer suppress the immune system ...
Injured optic nerves can regrow toward the brain if treated properly, University of Connecticut scientists report in the ...
Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive interim efficacy data from the Phase I stage of its ...
A recent study in Nature Materials introduces an inhalable nanozyme treatment for viral pneumonia, showing promising results ...
A stroma-myeloid niche composited of SPP1+tumour-associated macrophages and THBS2+matrix cancer-associated fibroblasts (mCAFs ... This study was approved by the Ethics Committee of Sun Yat-sen ...
Results Overall, 252 macrophage-associated myelin lesions were identified in longitudinal sections. Of these, 40 lesions exhibited complete demyelination with no association with the lamellar ...
Fostamatinib was approved in 2018 to treat adults with chronic immune thrombocytopenia (ITP) who had an insufficient response ...
further supporting that FABP4-mediated lipolysis in macrophages was critical for lipid utilization by breast cancer cells. TAMs are the most abundant immune cells in breast cancer. To interrogate ...